FIELD: organic chemistry, medicine, hematology.
SUBSTANCE: invention elates to new compounds that inhibit activated blood coagulating factor X (Fxa factor) eliciting the strong anti-coagulating effect. Invention proposes compound of the formula (1): Q1-Q2-C(=C)-N-(R1)-Q3-N(R2)-T1-Q4(1) wherein R1, R2, Q1, Q2, Q4 and T1 have corresponding values, and Q2 represents the group of the formula: wherein R9, R10 and Q5 have corresponding values also, or its salt, solvate or N-oxide. Invention provides the development of a novel compound possessing strong Fxa-inhibiting effect and showing the rapid, significant and stable anti-thrombosis effectin oral administration.
EFFECT: valuable medicinal properties of compounds.
13 cl, 1 tbl, 195 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF DIAMINES | 2002 |
|
RU2319699C2 |
DIAMINE DERIVATIVES | 2002 |
|
RU2314303C2 |
DIAMINE DERIVATIVES | 2003 |
|
RU2333203C2 |
GUANIDIN DERIVATIVES AND THEIR APPLICATION AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS | 2004 |
|
RU2337911C2 |
NOVEL COMPOUNDS | 2015 |
|
RU2691389C2 |
TETRAHYDRO-4N-PYRIDO[1,2-a]PYRIMIDINE AND RELATED COMPOUNDS, USED AS INHIBITORS OF HIV-INTEGRASE | 2003 |
|
RU2329265C2 |
NOVEL NUCLEOSIDES WITH BICYCLIC SUGAR MOIETY AND OLIGONUCLEOTIDES COMPRISING THEREOF | 1999 |
|
RU2211223C2 |
NOVEL PYRAZOLE DERIVATIVES | 2022 |
|
RU2816835C1 |
SUBSTITUTED DIALKYL (OXIDE)-Λ-SULFANILIDENE NICOTINAMIDE DERIVATIVES AS KINASE INHIBITORS | 2014 |
|
RU2711749C2 |
HETEROCYCLIC COMPUNDS WITH HIGHER EFFICIENCY COUPLING WITH CHEMOKINE RECEPTOR | 2002 |
|
RU2325387C2 |
Authors
Dates
2006-01-20—Published
2001-04-05—Filed